Navigation Links
New Treatment Option for Colorectal Cancer

Colorectal cancer causes about 10 percent of cancer deaths each year.Researchers say that doctors may soon have one more option // for patients who have colorectal cancer that resists standard chemotherapy treatment. New research shows the drug cetuximab, also known as Erbitux, may be a promising new therapy.

The standard treatment for colorectal cancer patients is the drug irinotecan (Camptosar) that can be given alone or with fluorouracil (Adrucil) and leucovorin (Wellcovorin). Oxaliplatin (Eloxatin) is another approved regimen that can be used. But for patients who do not respond to irinotecan, cetuximab may be the answer.

Cetuximab is in a new class of cancer drugs called targeted therapies because they attack cancer and leave healthy cells alone.Patients either received cetuximab and irinotecan or cetuximab alone. Researchers say, although modest, the patients on cetuximab alone or in combination with irinotecan saw improvements in survival.

Thus specialists say that Cetuximab combined with irinotecan offers patients with metastatic colorectal cancer another treatment option after failing treatment with irinotecan .
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment Option for Colorectal Cancer

(Date:7/7/2015)... ... July 07, 2015 , ... ... from Cambridge Consultants that discussed how innovation and technology would be the “key ... need to address issues of accessibility and affordability, especially in emerging and growing ...
(Date:7/7/2015)... ... July 07, 2015 , ... U.S. Rep. Mike ... expanded list of telehealth services available to Medicare beneficiaries. Thompson’s bill, the Medicare ... 3), Diane Black (R-TN 6) and Peter Welch (D-VT). , “This bi-partisan legislation ...
(Date:7/7/2015)... ... ... Today, the physicians at Allied Anesthesia, who provide services to Children’s Hospital ... released a series of tips to help children stay safe over the summer months. ... more unsupervised time outdoors. , The most common causes of injuries and death ...
(Date:7/7/2015)... SAN ANTONIO, Texas (PRWEB) , ... July 07, ... ... integrating advanced sensing technologies into everyday items, recently launched their first line of ... pre-order today and is expected to ship this fall. , ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... growth strategy expert Jay Warden as Senior Vice President, heading the firm’s Healthcare ... to provide the best solutions to healthcare providers’ needs in ways that strengthen ...
Breaking Medicine News(10 mins):Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:The American Telemedicine Association Supports Legislation to Expand Medicare Coverage for Telemedicine Services 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3
... Available to Discuss Breast Cancer Early Detection ... Breast Cancer Awareness Month, DALLAS, Oct. 1 ... proactive regarding breast cancer, U.S. Preventive Medicine(R),( http://www.USPreventiveMedicine.com ), ... prevention throughout America, today announced its,list of screenings to ...
... October 17 ... - 19, ... builds and enhances the foundation for success in all,five areas of ... three days, October 17 -,19, is designed to improve implementation, lower ...
... New Study Calls for Measures to Recognize Value ... Inadequate reimbursement,rates from private insurers threaten the ... centers (CHCs) and their ability to continue serving ... Community Health Care,Association of New York State (CHCANYS), ...
... Nearly Three Decades of Pharmaceutical ... Industry Experience and Leadership, ... ), a,leading, global full-service clinical research organization, today,announced the ... Safety and Pharmacovigilance. Dr. Hintze will lead the continued,growth ...
... with parents and schools to provide a bug busting approach ... health inequalities and reduce healthcare costs, according to a review ... A team from the UK charity Community Hygiene Concern led ... and Denmark since 1996. , The best results ...
... prostate cancer treatment called androgen deprivation therapy may encourage ... them more likely to spread throughout the body, a ... Although the finding could eventually lead to changes in ... Johns Hopkins researchers caution that their discovery is far ...
Cached Medicine News:Health News:Early Breast Cancer Detection Saves Lives 2Health News:Early Breast Cancer Detection Saves Lives 3Health News:Early Breast Cancer Detection Saves Lives 4Health News:Sign Up Now for Project Management Essentials - Three Days of Training in IT Project Management Fundamentals 2Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 2Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 3Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 4Health News:Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance 2Health News:Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance 3Health News:Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance 4Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 2Health News:Multicountry review shows that Bug Buster Kits reduce head lice and social stigma 3Health News:Standard treatment for prostate cancer may encourage spread of disease 2
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Inc. (Nasdaq: STRM ) today announced financial ... ended January 31, 2011. Highlights for the ... purchase contracts for add-on licenses with existing clients totaling ... recognized during the quarter; Company completed and ...
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
Cached Medicine Technology:Streamline Health® Solutions Reports Q4 Results 2Streamline Health® Solutions Reports Q4 Results 3Streamline Health® Solutions Reports Q4 Results 4Streamline Health® Solutions Reports Q4 Results 5Streamline Health® Solutions Reports Q4 Results 6Streamline Health® Solutions Reports Q4 Results 7Streamline Health® Solutions Reports Q4 Results 8Streamline Health® Solutions Reports Q4 Results 9Streamline Health® Solutions Reports Q4 Results 10Streamline Health® Solutions Reports Q4 Results 11Streamline Health® Solutions Reports Q4 Results 12Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: